Compounding Pharmacies Market Size, Share, Trends, Growth Outlook

Compounding Pharmacies Market is estimated to increase at a growth rate of 5.4% CAGR over the forecast period from 2024 to 2030.

The Compounding Pharmacies Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Therapeutic Area (Hormone replacement therapy, Pain management, Dermatology, Specialty drugs, Nutritional Supplements, Others), By Age Cohort, Pediatric, Adult, Geriatric), By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA), Others), By Sterility (Sterile, Non Sterile).

An Introduction to Compounding Pharmacies Market in 2024

The Compounding Pharmacies market in 2024 serves the demand for customized medications prepared by specialized compounding pharmacies to meet the unique medical needs and preferences of patients and animals. Compounding pharmacies prepare medications in specific formulations, strengths, and dosage forms that are not commercially available, allowing for individualized treatment regimens and tailored therapy solutions. Market dynamics are driven by factors such as the increasing demand for personalized medicine, the need for alternative dosage forms (liquids, transdermal gels) for patients unable to swallow pills, and the demand for veterinary medications in animal-friendly flavors and formulations. Collaboration between compounding pharmacists, healthcare providers, and patients/pet owners drives innovation and market growth in compounding pharmacies, ensuring access to safe, effective, and patient-specific medications for individuals and animals with unique medical requirements.

Compounding Pharmacies Market Trend: Increasing Demand for Personalized Medications

A significant trend in the Compounding Pharmacies market is the increasing demand for personalized medications. Patients are seeking customized pharmaceutical solutions tailored to their specific needs, such as unique dosage forms, flavors, and ingredient combinations that are not readily available in commercial medications. Compounding pharmacies offer the ability to create individualized medications based on patient preferences, allergies, and medical requirements, catering to niche markets and addressing unmet patient needs. This trend is driven by growing consumer awareness, a rise in chronic diseases, and the desire for alternative treatment options, propelling the growth of compounding pharmacy services globally.

Compounding Pharmacies Market Driver: Rising Prevalence of Drug Shortages and Discontinued Medications

The primary driver for the Compounding Pharmacies market is the rising prevalence of drug shortages and discontinued medications. Pharmaceutical manufacturers often face challenges in maintaining consistent supply chains, leading to shortages of essential medications or discontinuation of certain drug formulations. In such instances, compounding pharmacies play a crucial role in filling the gap by producing compounded medications to meet patient demand and address medication shortages. Additionally, compounding pharmacies offer alternatives for patients who may be allergic to certain ingredients in commercial medications or require specialized dosage forms not available in mass-produced drugs. The increasing occurrence of drug shortages and discontinuations drives the demand for compounding pharmacy services, driving market growth.

Compounding Pharmacies Market Opportunity: Expansion of Specialty Compounding Services

An opportunity in the Compounding Pharmacies market lies in the expansion of specialty compounding services. As the demand for personalized medications continues to rise, compounding pharmacies can capitalize on this trend by diversifying their service offerings to include specialty compounding services for niche therapeutic areas and patient populations. This includes compounding medications for veterinary use, pediatric patients, hormone replacement therapy, dermatology, pain management, and more. By investing in specialized equipment, training, and quality assurance measures, compounding pharmacies can enhance their capabilities to formulate complex medications and address specific patient needs effectively. Expanding into specialty compounding services allows compounding pharmacies to differentiate themselves in the market, attract new customers, and foster partnerships with healthcare providers, thereby unlocking growth opportunities in the Compounding Pharmacies market.

Compounding Pharmacies Market Segmentation

By Therapeutic Area
Hormone replacement therapy
Pain management
Dermatology
Specialty drugs
Nutritional Supplements
Others
By Age Cohort
Pediatric
Adult
Geriatric
By Compounding Type
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others
By Sterility
Sterile
Non Sterile
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Compounding Pharmacies Market Companies

B. Braun Medical Inc
Clinigen Group PLC
Dougherty's Pharmacy Inc
Fagron NV
Fresenius Kabi
Institutional Pharmacy Solutions
ITC Compounding Pharmacy
Lorraine's Pharmacy
Mcguff compounding pharmacy services
Pencol Compounding Pharmacy
Rx3 Compounding Pharmacy
Valor Compounding Pharmacy Inc
Wedgewood Pharmacy

 

 

Reasons to Buy the Compounding Pharmacies Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Compounding Pharmacies Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Compounding Pharmacies Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Compounding Pharmacies Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Compounding Pharmacies Market Size Outlook, $ Million, 2021 to 2030
3.2 Compounding Pharmacies Market Outlook by Type, $ Million, 2021 to 2030
3.3 Compounding Pharmacies Market Outlook by Product, $ Million, 2021 to 2030
3.4 Compounding Pharmacies Market Outlook by Application, $ Million, 2021 to 2030
3.5 Compounding Pharmacies Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Compounding Pharmacies Market Industry
4.2 Key Market Trends in Compounding Pharmacies Market Industry
4.3 Potential Opportunities in Compounding Pharmacies Market Industry
4.4 Key Challenges in Compounding Pharmacies Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Compounding Pharmacies Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Compounding Pharmacies Market Outlook By Segments
7.1 Compounding Pharmacies Market Outlook by Segments
By Therapeutic Area
Hormone replacement therapy
Pain management
Dermatology
Specialty drugs
Nutritional Supplements
Others
By Age Cohort
Pediatric
Adult
Geriatric
By Compounding Type
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others
By Sterility
Sterile
Non Sterile

8 North America Compounding Pharmacies Market Analysis And Outlook To 2030
8.1 Introduction to North America Compounding Pharmacies Markets in 2024
8.2 North America Compounding Pharmacies Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Compounding Pharmacies Market size Outlook by Segments, 2021-2030
By Therapeutic Area
Hormone replacement therapy
Pain management
Dermatology
Specialty drugs
Nutritional Supplements
Others
By Age Cohort
Pediatric
Adult
Geriatric
By Compounding Type
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others
By Sterility
Sterile
Non Sterile

9 Europe Compounding Pharmacies Market Analysis And Outlook To 2030
9.1 Introduction to Europe Compounding Pharmacies Markets in 2024
9.2 Europe Compounding Pharmacies Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Compounding Pharmacies Market Size Outlook By Segments, 2021-2030
By Therapeutic Area
Hormone replacement therapy
Pain management
Dermatology
Specialty drugs
Nutritional Supplements
Others
By Age Cohort
Pediatric
Adult
Geriatric
By Compounding Type
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others
By Sterility
Sterile
Non Sterile

10 Asia Pacific Compounding Pharmacies Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Compounding Pharmacies Markets in 2024
10.2 Asia Pacific Compounding Pharmacies Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Compounding Pharmacies Market size Outlook by Segments, 2021-2030
By Therapeutic Area
Hormone replacement therapy
Pain management
Dermatology
Specialty drugs
Nutritional Supplements
Others
By Age Cohort
Pediatric
Adult
Geriatric
By Compounding Type
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others
By Sterility
Sterile
Non Sterile

11 South America Compounding Pharmacies Market Analysis And Outlook To 2030
11.1 Introduction to South America Compounding Pharmacies Markets in 2024
11.2 South America Compounding Pharmacies Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Compounding Pharmacies Market size Outlook by Segments, 2021-2030
By Therapeutic Area
Hormone replacement therapy
Pain management
Dermatology
Specialty drugs
Nutritional Supplements
Others
By Age Cohort
Pediatric
Adult
Geriatric
By Compounding Type
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others
By Sterility
Sterile
Non Sterile

12 Middle East And Africa Compounding Pharmacies Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Compounding Pharmacies Markets in 2024
12.2 Middle East and Africa Compounding Pharmacies Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Compounding Pharmacies Market size Outlook by Segments, 2021-2030
By Therapeutic Area
Hormone replacement therapy
Pain management
Dermatology
Specialty drugs
Nutritional Supplements
Others
By Age Cohort
Pediatric
Adult
Geriatric
By Compounding Type
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others
By Sterility
Sterile
Non Sterile

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
B. Braun Medical Inc
Clinigen Group PLC
Dougherty's Pharmacy Inc
Fagron NV
Fresenius Kabi
Institutional Pharmacy Solutions
ITC Compounding Pharmacy
Lorraine's Pharmacy
Mcguff compounding pharmacy services
Pencol Compounding Pharmacy
Rx3 Compounding Pharmacy
Valor Compounding Pharmacy Inc
Wedgewood Pharmacy

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Therapeutic Area
Hormone replacement therapy
Pain management
Dermatology
Specialty drugs
Nutritional Supplements
Others
By Age Cohort
Pediatric
Adult
Geriatric
By Compounding Type
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others
By Sterility
Sterile
Non Sterile